Prof. Dr. Kayser Çağlar

Şehir: Ankara

Bölüm: Nefroloji

Adresler (1)

Memorial Ankara Hastanesi
Balgat Mahallesi Mevlana Bulvarı 1422.Sokak No:4

Prof. Dr. Kayser Çağlar

  • Hastane: Memorial Ankara Hastanesi

    Adres: Balgat Mahallesi Mevlana Bulvarı 1422.Sokak No:4

Prof. Dr. Kayser Çağlar Hakkında

Prof. Dr. Kayser Çağlar Kimdir?

Eğitimler

  • 1980 - 1986, Ankara/Türkiye
  • GATA Hastanesi

Deneyimler

  • 2025 - Halen, Ankara/Türkiye
  • Memorial Ankara Hastanesi
  • Nefroloji Uzmanı
  • 2016 - 2025, Ankara/Türkiye
  • Lösante Hastanesi
  • 2013 - 2016, Ankara/Türkiye
  • 2000 - 2001, Nashville/ABD
  • Vanderbilt Universiyt
  • 1995 - 2013, Ankara/Türkiye
  • GATA Hastanesi Nefroloji
  • Asistanlık / Uzmanlık / Öğretim Üyeliği
  • 1993 - 1995, Ağrı/Türkiye
  • Ağrı Askeri Hastanesi
  • İç Hastalıkları Uzmanı
  • 1989 - 1993, Ankara/Türkiye
  • GATA Hastanesi İç Hastalıklar
  • İç hastalıkları Uzmanı
  • 1987 - 1989, KKTC/KKTC
  • KKTC
  • Pratisyen Dr.

Yayınlar

  • 1: Solak Y, Yilmaz MI, Saglam M, Caglar K, Verim S, Unal HU, Gok M, Demirkaya E,
  • Gaipov A, Kayrak M, Cetinkaya H, Eyileten T, Turk S, Vural A. Red cell
  • distribution width is independently related to endothelial dysfunction in
  • patients with chronic kidney disease. Am J Med Sci. 2014 Feb;347(2):118-24. doi:
  • 10.1097/MAJ.0b013e3182996a96. PMID: 23928544.
  • 2: Solak Y, Yilmaz MI, Saglam M, Demirbas S, Verim S, Unal HU, Gaipov A, Oguz Y,
  • Kayrak M, Caglar K, Vural A, Turk S, Covic A, Kanbay M. Mean corpuscular volume
  • is associated with endothelial dysfunction and predicts composite cardiovascular
  • events in patients with chronic kidney disease. Nephrology (Carlton). 2013
  • Nov;18(11):728-35. doi: 10.1111/nep.12130. PMID: 23848392.
  • 3: Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Turker T, Unal HU, Gok M,
  • Cetinkaya H, Eyileten T, Oguz Y, Caglar K, Vural A, Mallamaci F, Zoccali C.
  • Longitudinal analysis of vascular function and biomarkers of metabolic bone
  • disorders before and after renal transplantation. Am J Nephrol.
  • 2013;37(2):126-34. doi: 10.1159/000346711. Epub 2013 Jan 31. PMID: 23391995.
  • 4: Solak Y, Yilmaz MI, Sonmez A, Saglam M, Cakir E, Unal HU, Gok M, Caglar K,
  • Oguz Y, Yenicesu M, Karaman M, Ay SA, Gaipov A, Turk S, Vural A, Carrero JJ.
  • Neutrophil to lymphocyte ratio independently predicts cardiovascular events in
  • patients with chronic kidney disease. Clin Exp Nephrol. 2013 Aug;17(4):532-40.
  • doi: 10.1007/s10157-012-0728-x. Epub 2012 Nov 20. PMID: 23180042.
  • 5: Kanbay M, Yilmaz MI, Sonmez A, Solak Y, Saglam M, Cakir E, Unal HU, Arslan E,
  • Verim S, Madero M, Caglar K, Oguz Y, McFann K, Johnson RJ. Serum uric acid
  • independently predicts cardiovascular events in advanced nephropathy. Am J
  • Nephrol. 2012;36(4):324-31. doi: 10.1159/000342390. Epub 2012 Sep 22. PMID:
  • 23007099.
  • 6: Kanbay M, Yilmaz MI, Apetrii M, Saglam M, Yaman H, Unal HU, Gok M, Caglar K,
  • Oguz Y, Yenicesu M, Cetinkaya H, Eyileten T, Acikel C, Vural A, Covic A.
  • Relationship between serum magnesium levels and cardiovascular events in chronic
  • kidney disease patients. Am J Nephrol. 2012;36(3):228-37. doi:
  • 10.1159/000341868. Epub 2012 Aug 30. PMID: 22948239.
  • 7: Kanbay M, Yilmaz MI, Afsar B, Saglam M, Akgul EO, Cayci T, Caglar K, Unal HU,
  • Gok M, Vural A, Covic A. Serum calcitonin and endothelial dysfunction in chronic
  • kidney disease: a novel risk factor? Int Urol Nephrol. 2013 Feb;45(1):151-6.
  • doi: 10.1007/s11255-012-0158-4. Epub 2012 Mar 23. PMID: 22437807.
  • 8: Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Eyileten T, Caglar K, Oguz
  • Y, Vural A, Yenicesu M, Mallamaci F, Zoccali C. Comparison of calcium acetate
  • and sevelamer on vascular function and fibroblast growth factor 23 in CKD
  • patients: a randomized clinical trial. Am J Kidney Dis. 2012 Feb;59(2):177-85.
  • doi: 10.1053/j.ajkd.2011.11.007. Epub 2011 Dec 2. PMID: 22137672.
  • 9: Yilmaz MI, Sonmez A, Qureshi AR, Saglam M, Stenvinkel P, Yaman H, Eyileten T,
  • Caglar K, Oguz Y, Taslipinar A, Vural A, Gok M, Unal HU, Yenicesu M, Carrero JJ.
  • Endogenous testosterone, endothelial dysfunction, and cardiovascular events in
  • men with nondialysis chronic kidney disease. Clin J Am Soc Nephrol. 2011
  • Jul;6(7):1617-25. doi: 10.2215/CJN.10681210. Epub 2011 Jun 23. PMID: 21700826.
  • 10: Yilmaz MI, Stenvinkel P, Sonmez A, Saglam M, Yaman H, Kilic S, Eyileten T,
  • Caglar K, Oguz Y, Vural A, Çakar M, Altun B, Yenicesu M, Carrero JJ. Vascular
  • health, systemic inflammation and progressive reduction in kidney function;
  • clinical determinants and impact on cardiovascular outcomes. Nephrol Dial
  • Transplant. 2011 Nov;26(11):3537-43. doi: 10.1093/ndt/gfr081. Epub 2011 Mar 4.
  • PMID: 21378154.
  • 11: Yilmaz MI, Sonmez A, Ortiz A, Saglam M, Kilic S, Eyileten T, Caglar K, Oguz
  • Y, Vural A, Çakar M, Egido J, Altun B, Yenicesu M, Blanco-Colio LM, Carrero JJ.
  • Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial
  • dysfunction and cardiovascular outcomes. Clin J Am Soc Nephrol. 2011
  • Apr;6(4):785-92. doi: 10.2215/CJN.09231010. Epub 2011 Feb 17. PMID: 21330486;
  • PMCID: PMC3069370.
  • 12: Yilmaz MI, Sonmez A, Karaman M, Ay SA, Saglam M, Yaman H, Kilic S, Eyileten
  • T, Caglar K, Oguz Y, Vural A, Yenicesu M, Zoccali C. Low triiodothyronine alters
  • flow-mediated vasodilatation in advanced nondiabetic kidney disease. Am J
  • Nephrol. 2011;33(1):25-32. doi: 10.1159/000322581. Epub 2010 Dec 9. PMID:
  • 21150192.
  • 13: Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Demirkaya E, Eyileten T,
  • Caglar K, Oguz Y, Vural A, Yenicesu M, Zoccali C. FGF-23 and vascular
  • dysfunction in patients with stage 3 and 4 chronic kidney disease. Kidney Int.
  • 2010 Oct;78(7):679-85. doi: 10.1038/ki.2010.194. Epub 2010 Jul 7. PMID:
  • 20613714.
  • 14: Eyileten T, Sonmez A, Saglam M, Cakir E, Caglar K, Oguz Y, Vural A, Yenicesu
  • M, Yilmaz MI. Effect of renin-angiotensin-aldosterone system (RAAS) blockade on
  • visfatin levels in diabetic nephropathy. Nephrology (Carlton). 2010
  • Mar;15(2):225-9. doi: 10.1111/j.1440-1797.2009.01173.x. PMID: 20470283.
  • 15: Afsar B, Afsar RE, Sen ST, Kirkpantur A, Eyileten T, Yilmaz MI, Caglar K.
  • Simple renal cysts and circadian blood pressure: are they related to each other
  • in patients with hypertension? Int Urol Nephrol. 2011 Mar;43(1):157-65. doi:
  • 10.1007/s11255-010-9734-7. Epub 2010 Apr 13. PMID: 20390353.
  • 16: Yilmaz MI, Sonmez A, Saglam M, Yaman H, Cayci T, Kilic S, Eyileten T, Caglar
  • K, Oguz Y, Vural A, Yenicesu M, Axelsson J. Reduced proteinuria using ramipril
  • in diabetic CKD stage 1 decreases circulating cell death receptor activators
  • concurrently with ADMA. A novel pathophysiological pathway? Nephrol Dial
  • Transplant. 2010 Oct;25(10):3250-6. doi: 10.1093/ndt/gfq159. Epub 2010 Mar 26.
  • PMID: 20348148.
  • 17: Yilmaz MI, Qureshi AR, Carrero JJ, Saglam M, Suliman ME, Caglar K, Eyileten
  • doi: 10.1159/000272936. Epub 2009 Dec 31. PMID: 20068285
  • T, Sonmez A, Oguz Y, Vural A, Yenicesu M, Axelsson J. Predictors of carotid
  • artery intima-media thickness in chronic kidney disease and kidney transplant
  • patients without overt cardiovascular disease. Am J Nephrol. 2010;31(3):214-21.
  • 18: Sonmez A, Yilmaz MI, Saglam M, Kilic S, Eyileten T, Uckaya G, Caglar K, Oguz
  • Y, Vural A, Yenicesu M, Kutlu M, Kinalp C, Zoccali C. The relationship between
  • hemoglobin levels and endothelial functions in diabetes mellitus. Clin J Am Soc
  • Nephrol. 2010 Jan;5(1):45-50. doi: 10.2215/CJN.05080709. Epub 2009 Oct 15. PMID:
  • 19833907; PMCID: PMC2801645.
  • 19: Afsar B, Elsurer R, Eyileten T, Yilmaz MI, Caglar K. Antibody response
  • following hepatitis B vaccination in dialysis patients: does depression and life
  • quality matter? Vaccine. 2009 Sep 25;27(42):5865-9. doi:
  • 10.1016/j.vaccine.2009.07.055. Epub 2009 Aug 3. PMID: 19654067.
  • 20: Yilmaz MI, Saglam M, Carrero JJ, Qureshi AR, Caglar K, Eyileten T, Sonmez A,
  • Oguz Y, Aslan I, Vural A, Yenicesu M, Stenvinkel P, Lindholm B, Axelsson J.
  • Normalization of endothelial dysfunction following renal transplantation is
  • accompanied by a reduction of circulating visfatin/NAMPT. A novel marker of
  • endothelial damage? Clin Transplant. 2009 Mar-Apr;23(2):241-8. doi:
  • 10.1111/j.1399-0012.2008.00921.x. PMID: 19402217.
  • 21: Yilmaz MI, Sonmez A, Saglam M, Gulec M, Kilic S, Eyileten T, Caglar K, Oguz
  • Y, Vural A, Yenicesu M, Zoccali C. Hemoglobin is inversely related to flow-
  • mediated dilatation in chronic kidney disease. Kidney Int. 2009
  • Jun;75(12):1316-1321. doi: 10.1038/ki.2009.63. Epub 2009 Mar 4. PMID: 19262460.
  • 22: Yilmaz MI, Axelsson J, Sonmez A, Carrero JJ, Saglam M, Eyileten T, Caglar K,
  • Kirkpantur A, Celik T, Oguz Y, Vural A, Yenicesu M, Lindholm B, Stenvinkel P.
  • Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2
  • diabetic patients with proteinuria. Clin J Am Soc Nephrol. 2009 Mar;4(3):535-41.
  • doi: 10.2215/CJN.04330808. Epub 2009 Feb 11. PMID: 19211665; PMCID: PMC2653664.
  • 23: Oguz Y, Yilmaz MI, Acikel C, Eyileten T, Caglar K, Oktenli C, Yenicesu M,
  • Vural A. The relationship between adiponectin levels and degree of proteinuria
  • in patients with nephrotic and non-nephrotic proteinuria. Ren Fail.
  • 2009;31(1):29-35. doi: 10.1080/08860220802546461. PMID: 19142807.
  • 24: Beyzadeoglu M, Arpaci F, Surenkok S, Ozyigit G, Oysul K, Caglar K, Ataergin
  • S, Yenicesu M, Kaya A. Acute renal toxicity of 2 conditioning regimens in
  • patients undergoing autologous peripheral blood stem-cell transplantation. Total
  • body irradiation-cyclophosphamide versus ifosfamide, carboplatin, etoposide.
  • Saudi Med J. 2008 Jun;29(6):832-6. PMID: 18521460.
  • 25: Caglar K, Yilmaz MI, Saglam M, Cakir E, Kilic S, Sonmez A, Eyileten T,
  • Yenicesu M, Oguz Y, Tasar M, Vural A, Ikizler TA, Stenvinkel P, Lindholm B.
  • Serum fetuin-a concentration and endothelial dysfunction in chronic kidney
  • disease. Nephron Clin Pract. 2008;108(3):c233-40. doi: 10.1159/000120209. Epub
  • 2008 Mar 11. PMID: 18334823.
  • 26: Yilmaz MI, Sonmez A, Saglam M, Qureshi AR, Carrero JJ, Caglar K, Eyileten T,
  • 10.1681/ASN.2007040461. Epub 2008 Jan 16. PMID: 18199801; PMCID: PMC2396733
  • Cakir E, Oguz Y, Vural A, Yenicesu M, Lindholm B, Stenvinkel P, Axelsson J. ADMA
  • levels correlate with proteinuria, secondary amyloidosis, and endothelial
  • dysfunction. J Am Soc Nephrol. 2008 Feb;19(2):388-95. doi:
  • 27: Yilmaz MI, Saglam M, Qureshi AR, Carrero JJ, Caglar K, Eyileten T, Sonmez A,
  • Cakir E, Oguz Y, Vural A, Yenicesu M, Stenvinkel P, Lindholm B, Axelsson J.
  • Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is
  • associated with low circulating adiponectin. Nephrol Dial Transplant. 2008
  • May;23(5):1621-7. doi: 10.1093/ndt/gfm828. Epub 2008 Jan 5. PMID: 18175782.
  • 28: onmez A, Yilmaz MI, Korkmaz A, Topal T, Caglar K, Kaya A, Eyileten T,
  • Yenicesu M, Oguz Y, Basal S, Ipcioglu OM, Vural A. Hyperbaric oxygen treatment
  • augments the efficacy of cilazapril and simvastatin regimens in an experimental
  • nephrotic syndrome model. Clin Exp Nephrol. 2008 Apr;12(2):110-118. doi:
  • 10.1007/s10157-007-0017-2. Epub 2008 Jan 5. PMID: 18175058.
  • 29: Caglar K, Yilmaz MI, Saglam M, Cakir E, Acikel C, Eyileten T, Yenicesu M,
  • Oguz Y, Vural A, Carrero JJ, Axelsson J, Lindholm B, Stenvinkel P. Short-term
  • treatment with sevelamer increases serum fetuin-a concentration and improves
  • endothelial dysfunction in chronic kidney disease stage 4 patients. Clin J Am
  • Soc Nephrol. 2008 Jan;3(1):61-8. doi: 10.2215/CJN.02810707. Epub 2007 Dec 5.
  • PMID: 18057307; PMCID: PMC2390988.
  • 30: Yilmaz MI, Saglam M, Carrero JJ, Qureshi AR, Caglar K, Eyileten T, Sonmez A,
  • Cakir E, Yenicesu M, Lindholm B, Stenvinkel P, Axelsson J. Serum visfatin
  • concentration and endothelial dysfunction in chronic kidney disease. Nephrol
  • Dial Transplant. 2008 Mar;23(3):959-65. doi: 10.1093/ndt/gfm727. Epub 2007 Nov
  • 4. PMID: 17984105.
  • 31: Kara B, Caglar K, Kilic S. Nonadherence with diet and fluid restrictions and
  • perceived social support in patients receiving hemodialysis. J Nurs Scholarsh.
  • 2007;39(3):243-8. doi: 10.1111/j.1547-5069.2007.00175.x. PMID: 17760797.
  • 32: Yilmaz I, Saglam M, Sonmez A, Caglar K, Cakir E, Kurt Y, Eyileten T, Tasar
  • M, Acikel C, Oguz Y, Vural A, Yenicesu M. Improving proteinuria, endothelial
  • functions and asymmetric dimethylarginine levels in chronic kidney disease:
  • ramipril versus valsartan. Blood Purif. 2007;25(4):327-35. doi:
  • 10.1159/000107410. Epub 2007 Aug 20. PMID: 17709915.
  • 33: Yilmaz MI, Sonmez A, Caglar K, Celik T, Yenicesu M, Eyileten T, Acikel C,
  • Oguz Y, Yavuz I, Vural A. Effect of antihypertensive agents on plasma
  • adiponectin levels in hypertensive patients with metabolic syndrome. Nephrology
  • (Carlton). 2007 Apr;12(2):147-53. doi: 10.1111/j.1440-1797.2007.00764.x. PMID:
  • 17371337.
  • 34: Caglar K, Yilmaz MI, Saglam M, Cakir E, Kilic S, Eyileten T, Sonmez A, Oguz
  • Y, Oner K, Ors F, Vural A, Yenicesu M. Endothelial dysfunction and fetuin A
  • levels before and after kidney transplantation. Transplantation. 2007 Feb
  • 27;83(4):392-7. doi: 10.1097/01.tp.0000251647.72673.c7. PMID: 17318070.
  • 35: Caglar K, Yilmaz MI, Sonmez A, Cakir E, Kaya A, Acikel C, Eyileten T,
  • 16820789
  • Yenicesu M, Oguz Y, Bilgi C, Oktenli C, Vural A, Zoccali C. ADMA, proteinuria,
  • and insulin resistance in non-diabetic stage I chronic kidney disease. Kidney
  • Int. 2006 Aug;70(4):781-7. doi: 10.1038/sj.ki.5001632. Epub 2006 Jul 5. PMID:
  • 36: Oguz Y, Yilmaz MI, Eyileten T, Caglar K, Yenicesu M, Kaya A, Tasar M, Saglam
  • M, Doganci L, Gulec B, Oner K, Oktenli C, Vural A. Persistent mediastinal and
  • axillary lymph node tuberculosis in a renal transplant patient with successful
  • outcome. Transplant Proc. 2006 Jun;38(5):1336-40. doi:
  • 10.1016/j.transproceed.2006.03.038. PMID: 16797296.
  • 37: Avcu F, Ural AU, Yilmaz MI, Bingol N, Nevruz O, Caglar K. Association of
  • plasma adiponectin concentrations with chronic lymphocytic leukemia and
  • myeloproliferative diseases. Int J Hematol. 2006 Apr;83(3):254-8. doi:
  • 10.1532/IJH97.NA0411. PMID: 16720558.
  • 38: Yilmaz MI, Korkmaz A, Kaya A, Sonmez A, Caglar K, Topal T, Eyileten T,
  • Yenicesu M, Acikel C, Oter S, Yaman H, Aktug H, Oguz Y, Vural A, Ikizler TA.
  • Hyperbaric oxygen treatment augments the efficacy of a losartan regime in an
  • experimental nephrotic syndrome model. Nephron Exp Nephrol. 2006;104(1):e15-22.
  • doi: 10.1159/000093260. Epub 2006 May 11. PMID: 16699289.
  • 39: Yilmaz MI, Saglam M, Caglar K, Cakir E, Ozgurtas T, Sonmez A, Eyileten T,
  • Yenicesu M, Acikel C, Oguz Y, Ozcan O, Bozlar U, Erbil K, Aslan I, Vural A.
  • Endothelial functions improve with decrease in asymmetric dimethylarginine
  • (ADMA) levels after renal transplantation. Transplantation. 2005 Dec
  • 27;80(12):1660-6. doi: 10.1097/01.tp.0000183750.22675.be. PMID: 16378057.
  • 40: Yilmaz MI, Saglam M, Caglar K, Cakir E, Sonmez A, Ozgurtas T, Aydin A,
  • Eyileten T, Ozcan O, Acikel C, Tasar M, Genctoy G, Erbil K, Vural A, Zoccali C.
  • The determinants of endothelial dysfunction in CKD: oxidative stress and
  • asymmetric dimethylarginine. Am J Kidney Dis. 2006 Jan;47(1):42-50. doi:
  • 10.1053/j.ajkd.2005.09.029. PMID: 16377384.
  • 41: Yenicesu M, Yilmaz MI, Caglar K, Sonmez A, Eyileten T, Kir T, Acikel C,
  • Bingol N, Oguz Y, Ikizler TA, Vural A. Adiponectin level is reduced and
  • inversely correlated with the degree of proteinuria in type 2 diabetic patients.
  • Clin Nephrol. 2005 Jul;64(1):12-9. doi: 10.5414/cnp64012. PMID: 16047640.
  • 42: Vural A, Yilmaz MI, Caglar K, Aydin A, Sonmez A, Eyileten T, Acikel C, Gulec
  • B, Kozak O, Oner K. Assessment of oxidative stress in the early posttransplant
  • period: comparison of cyclosporine A and tacrolimus-based regimens. Am J
  • Nephrol. 2005 May-Jun;25(3):250-5. doi: 10.1159/000086079. Epub 2005 May 27.
  • PMID: 15925859.
  • 43: Goktas S, Yilmaz MI, Caglar K, Sonmez A, Kilic S, Bedir S. Prostate cancer
  • and adiponectin. Urology. 2005 Jun;65(6):1168-72. doi:
  • 10.1016/j.urology.2004.12.053. PMID: 15922427.
  • 44: Yilmaz MI, Sonmez A, Caglar K, Gok DE, Eyileten T, Yenicesu M, Acikel C,
  • 45: Yenicesu M, Yilmaz MI, Caglar K, Sonmez A, Eyileten T, Acikel C, Kilic S,
  • Bingol N, Kilic S, Oguz Y, Vural A. Peroxisome proliferator-activated receptor
  • gamma (PPAR-gamma) agonist increases plasma adiponectin levels in type 2
  • diabetic patients with proteinuria. Endocrine. 2004 Dec;25(3):207-14. doi:
  • 10.1385/ENDO:25:3:207. PMID: 15758247.
  • Bingol N, Bingol S, Vural A. Blockade of the renin-angiotensin system increases
  • plasma adiponectin levels in type-2 diabetic patients with proteinuria. Nephron
  • Clin Pract. 2005;99(4):c115-21. doi: 10.1159/000083929. Epub 2005 Feb 10. PMID:
  • 15711099.
  • 46: Pupim LB, Caglar K, Hakim RM, Shyr Y, Ikizler TA. Uremic malnutrition is a
  • predictor of death independent of inflammatory status. Kidney Int. 2004
  • Nov;66(5):2054-60. doi: 10.1111/j.1523-1755.2004.00978.x. PMID: 15496179.
  • 47: Demirkiliç U, Kuralay E, Yenicesu M, Cağlar K, Oz BS, Cingöz F, Günay C,
  • Yildirim V, Ceylan S, Arslan M, Vural A, Tatar H. Timing of replacement therapy
  • for acute renal failure after cardiac surgery. J Card Surg. 2004 Jan-
  • Feb;19(1):17-20. doi: 10.1111/j.0886-0440.2004.04004.x. PMID: 15108784.
  • glar K, Odabasi Z, Safali M, Yenicesu M, Vural A. Colchicine-induced
  • myopathy with myotonia in a patient with chronic renal failure. Clin Neurol
  • Neurosurg. 2003 Sep;105(4):274-6. doi: 10.1016/s0303-8467(03)00030-1. PMID:
  • 12954545.
  • 49: Caglar K, Hakim RM, Ikizler TA. Approaches to the reversal of malnutrition,
  • inflammation, and atherosclerosis in end-stage renal disease. Nutr Rev. 2002
  • Nov;60(11):378-87. doi: 10.1301/00296640260385928. PMID: 12462522.
  • 50: Caglar K, Kinalp C, Arpaci F, Turan M, Saglam K, Ozturk B, Komurcu S, Yavuz
  • I, Yenicesu M, Ozet A, Vural A. Cumulative prior dose of cisplatin as a cause of
  • the nephrotoxicity of high-dose chemotherapy followed by autologous stem-cell
  • transplantation. Nephrol Dial Transplant. 2002 Nov;17(11):1931-5. doi:
  • 10.1093/ndt/17.11.1931. PMID: 12401849.
  • 51: Caglar K, Safali M, Yavuz I, Odabaşi Z, Yenicesu M, Vural A. Colchicine-
  • induced myopathy with normal creatine phosphokinase level in a renal transplant
  • patient. Nephron. 2002 Dec;92(4):922-4. doi: 10.1159/000065439. PMID: 12399640.
  • 52: Caglar K, Peng Y, Pupim LB, Flakoll PJ, Levenhagen D, Hakim RM, Ikizler TA.
  • Inflammatory signals associated with hemodialysis. Kidney Int. 2002
  • Oct;62(4):1408-16. doi: 10.1111/j.1523-1755.2002.kid556.x. PMID: 12234313.
  • 53: Caglar K, Fedje L, Dimmitt R, Hakim RM, Shyr Y, Ikizler TA. Therapeutic
  • effects of oral nutritional supplementation during hemodialysis. Kidney Int.
  • 2002 Sep;62(3):1054-9. doi: 10.1046/j.1523-1755.2002.00530.x. PMID: 12164890.
  • 54: Pupim LB, Kent P, Caglar K, Shyr Y, Hakim RM, Ikizler TA. Improvement in
  • nutritional parameters after initiation of chronic hemodialysis. Am J Kidney
  • Dis. 2002 Jul;40(1):143-51. doi: 10.1053/ajkd.2002.33923. PMID: 12087572.
  • 55: Caglar K, Orhan ME, Gulec B, Yavuz I, Yenicesu M, Guzeldemir E, Vural A.
  • 56: Ozata M, Oktenli C, Gulec M, Ozgurtas T, Bulucu F, Caglar K, Bingol N, Vural
  • Severe rhabdomyolysis due to malignant hyperthermia during renal transplantation
  • 57: Cağlar K, Kibar Y, Tahmaz L, Safali M. Laser therapy in patient with
  • intractable haemorrhage due to the bladder involvement of systemic amyloidosis.
  • Mediterranean fever. Clin Exp Rheumatol. 2000 Nov-Dec;18(6):787-8. PMID:
  • 11138354.
  • 60: Vural A, Oguz Y, Oktenli C, Yenicesu M, Caglar K, Tanboga H. Detection of
  • source of haematuria after extracorporeal shock wave lithotripsy (ESWL) by
  • automated measurement of urinary red cell volume. Int Urol Nephrol.
  • 1998;30(1):31-7. doi: 10.1007/BF02550274. PMID: 9569108.
  • 61: Bulucu F, Vural A, Yenicesu M, Caglar K. Association of Gitelman's syndrome
  • and focal glomerulosclerosis. Nephron. 1998;79(2):244. doi: 10.1159/000045043.
  • PMID: 9647519.
  • Nephrol Dial Transplant. 2001 Aug;16(8):1724. doi: 10.1093/ndt/16.8.1724. PMID:
  • 11477190.
  • 58: Caglar K, Kibar Y, Tahmaz L, Tekin A, Yenicesu M, Vural A. Polycystic
  • 59: Dinc A, Simsek I, Pay S, Caglar K, Can C. Fabry's disease mimicking familial
  • horseshoe kidney. Clin Nephrol. 2001 Jun;55(6):487-8. PMID: 11434362.
  • procedure can cause delayed graft function. Am J Nephrol. 2002 Jan-
  • Feb;22(1):81-3. doi: 10.1159/000046678. PMID: 11919407.

Değerlendirmeler

Değerlendir
  • User Image
    Hasta: zü...e

    Puan: 5 / 5

    Tarih: 20 Nisan 2012, 21:27

    Yorum: hocalarin en iyisi.annemin saglıgı, ayakda oldugu için size hayatımı versem az bel?.sizin kibi doktorlar malesef az.siz pisikoloji doktoru olsaydınız, bir tane akılsız kalmazdı sayenizde, her kesin aklı başında olurdu.iyi ki varsınız hocam.kaç insanın dializ hastası olmasını engellemişsiniz.sizin için ne söylesem az.

Değerlendirmeler

Değerlendir
  • User Image
    zü...e
    20 Nisan 2012, 21:27

    hocalarin en iyisi.annemin saglıgı, ayakda oldugu için size hayatımı versem az bel?.sizin kibi doktorlar malesef az.siz pisikoloji doktoru olsaydınız, bir tane akılsız kalmazdı sayenizde, her kesin aklı başında olurdu.iyi ki varsınız hocam.kaç insanın dializ hastası olmasını engellemişsiniz.sizin için ne söylesem az.

Hasta Soruları

Randevu Alın

Bu uzmanın online randevu alabileceğiniz bir takvimi bulunmuyor.

Randevu takvimi talep edin

Bu Siz Misiniz?

Bilgilerinizi hemen bize iletin. Kontroller tamamlandığında, sayfanızı yönetmeye başlayabilmeniz için size gerekli erişim bilgilerini sağlayalım.

Profildeki bir bilginin yanlış veya güncel olmadığını düşünüyorsanız bize bildirin. Talebiniz moderatörlerimiz tarafından incelenecektir.

Sahiplen Düzeltme İste